All News

Max The Butterfly: Hope and Resurrection After Cancer

July 18th 2025, 5:00pm

Article

Butterflies are believed to be a symbol of resurrection and hope. This is an inspiring story about this phenomenon.

FDA Votes Against Proposed Blenrep Treatment Combo’s for Multiple Myeloma

July 18th 2025, 4:00pm

Article

The FDA's Oncologic Drugs Advisory Committee has casted their votes on the utilization of certain treatments in the multiple myeloma patient population.

FDA Grants Priority Review to TAR-200 for Bladder Cancer Subset

July 18th 2025, 3:00pm

Article

FDA grants priority review to TAR-200, which demonstrated an 82% complete response in high-risk bladder cancer unresponsive to Bacillus Calmette-Guérin.

Ojjaara May Improve Anemia and Reduce Transfusions in Myelofibrosis

July 18th 2025, 1:00pm

Video

An expert highlights the impact of anemia in myelofibrosis and presented Ojjaara as a possible treatment to reduce transfusions and improve outcomes.

What’s in a Name? How I Chose ‘Person’ Over ‘Survivor’ After Cancer

July 17th 2025, 9:00pm

Article

When asked to choose a word other than “survivor” to describe myself, I chose “person” because cancer does not define who I am.

Regaining Independence After Ovarian Cancer Surgery

July 17th 2025, 8:00pm

Video

After ovarian cancer surgery, Mary Barbera spent three months in rehab before finally returning home, a milestone that marked her emotional recovery.

Enhertu Combo Receives FDA Designation in Metastatic HER2+ Breast Cancer

July 17th 2025, 7:13pm

Article

The FDA granted breakthrough therapy designation to first-line treatment with Enhertu plus Perjeta for unresectable or metastatic HER2+ breast cancer.

Writing Helped Me Heal After Pancreatic Cancer

July 17th 2025, 5:00pm

Article

Cancer leaves deep emotional scars long after treatment ends, but for many survivors, honest, unfiltered writing can be a powerful path to healing.

Key Skin Cancer Treatment Updates From 2025 and What is Still to Come

July 17th 2025, 4:05pm

Article

Dr. Ma discussed key findings that have been shared so far this year on the topic of evolving treatment strategies for patients with high-risk skin cancer.

FDA Grants Orphan Status to Liquid Glioma Treatment SH-110

July 17th 2025, 3:14pm

Article

SH-110, a liquid cancer treatment for glioma, earned orphan drug status from the FDA, helping patients who struggle to swallow pills access therapy.